TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bio Forte AS
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
782
|
1,251 | |
| Financial expenses |
1
|
1 | |
| Earnings before taxes |
-17
|
44 | |
| Total assets |
305
|
413 | |
| Current assets |
268
|
384 | |
| Current liabilities |
38
|
114 | |
| Equity capital |
267
|
299 | |
| - share capital |
17
|
18 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
87.5%
|
72.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.2%
|
3.5% | |
| Return on assets (ROA) |
-5.2%
|
10.9% | |
| Current ratio |
705.3%
|
336.8% | |
| Return on equity (ROE) |
-6.4%
|
14.7% | |
| Change turnover |
-405
|
-5 | |
| Change turnover % |
21%
|
-34%
|
0% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.